Neonatal iron overload and tissue siderosis due to gestational alloimmune liver disease

Silvana Bonilla1, Joshua D Prozialeck, Padmini Malladi

  • 1Children's Memorial Research Center, The Feinberg School of Medicine of Northwestern University, Chicago, IL 60614, USA.

Journal of Hepatology
|February 11, 2012
PubMed

Insights

Fetal liver injury in gestational alloimmune liver disease causes iron overload due to reduced hepcidin production. Extrahepatic tissue siderosis patterns are linked to normal iron import and export protein expression.

Area of Science:

  • Hepatology
  • Neonatology
  • Iron Metabolism

Background:

  • Gestational alloimmune liver disease (GALD) causes neonatal hemochromatosis, characterized by severe liver disease, iron overload, and extrahepatic siderosis.
  • The mechanism by which fetal liver disease leads to extrahepatic siderosis remains unclear.

Purpose of the Study:

  • To investigate the hypothesis that fetal liver injury in GALD impairs hepcidin production and placental iron regulation.
  • To elucidate the factors determining the pattern of extrahepatic siderosis in GALD.

Main Methods:

  • Comparative analysis of liver and extrahepatic tissues from infants with GALD and age-matched controls.
  • Assessment of iron indices, gene expression of iron regulatory proteins (hepcidin, hemojuvelin, transferrin), and iron transporters (ZIP14, ferroportin).

Main Results:

  • Infants with GALD exhibit iron overload and excess non-transferrin-bound iron.
  • Diseased livers show significantly reduced expression of hepcidin, hemojuvelin, and transferrin.
  • Extrahepatic tissues consistently express ZIP14 for iron uptake and minimal ferroportin for iron export.

Conclusions:

  • Reduced synthesis of iron regulatory and transport proteins in GALD-affected fetal livers contributes to excess non-transferrin-bound iron.
  • The distribution of extrahepatic siderosis is dictated by the inherent tissue capacity for non-transferrin-bound iron import and limited iron export.
Abstract

Related Concept Videos

Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become anucleated and die, but their...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Inborn Errors of Metabolism01:20

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...